Back to YC Companies

    Kopra Bio

    Summer 2024
    Active

    Genetically engineered viruses that teach your immune system to kill…

    2 people View on YC

    Kopra Bio at a glance

    Y Combinator batch
    Summer 2024
    Status
    Active
    Industry
    Healthcare
    Team size
    2 people
    Location
    Not recorded
    Website
    Not recorded

    Every field above comes from the Y Combinator company record. Nothing is estimated.

    Compare Kopra Bio with similar YC companies →

    About Kopra Bio

    Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.

    Tags:
    Gene Therapy
    Synthetic Biology
    Biotech
    Therapeutics
    Oncology